Micrococcus luteus (Schroeter) Cohn 拉丁名
(ATCC? 10240?) 統(tǒng)一編號
Deposited As Micrococcus flavus Trevisan
Strain Designations 菌株別名 130.21 [ATCC 10786]
Application 用途 Assay of bacitracin Quality control strain Food testing Pharmaceutical and Personal Care Isolation Air
Biosafety Level 生物安全等級 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Storage Conditions 保藏條件
Frozen 冷凍物: -80℃ or colder
Freeze-Dried 凍干物: 2℃ to 8℃
Live Culture 活物: See Propagation Section
Preceptrol? no
Type Strain 模式菌株 no
Medium 培養(yǎng)基 ATCC? Medium 3: Nutrient agar or nutrient broth
Growth Conditions 生長條件
Temperature 培養(yǎng)溫度: 30℃
Atmosphere 需氧情況: Aerobic
Name of Depositor 寄存人 Commercial Solvents Corp.
Chain of Custody 來源國家 ATCC <-- Commercial Solvents Corp. <-- AR Stanley
Isolation 分離基物 Air
References 參考文獻 British Pharmacopoeia Commission Biological assay of antibiotics. London, UK:British Pharmacopoeia Commission;British Pharmacopoeia Appendix XIV A, 2003
AOAC International Bacitracin-MD (BMD) in complete feed, microbiological plate assay method. Gaithersburg, MD:AOAC International;AOAC "Official Methods of Analysis of the AOAC International" 993.29.
European Pharmacopoeia Commission Microbiological assay of antibiotics. Strasbourg, France:European Pharmacopoeia Commission;European Pharmacopoeia EP 2.7.2, 1997
U.S. Pharmacopeia General Chapters;Antibiotics-Microbial Assays. Rockville, MD: U.S. Pharmacopeia; USP USP34-NF29, 2011
AOAC International Antibiotics in feeds, microbiological methods. Gaithersburg, MD:AOAC International;AOAC "Official Methods of Analysis of the AOAC International" 957.23. AOAC International Bacitracin in premix feeds. Gaithersburg, MD:AOAC International;AOAC "Official Methods of Analysis of the AOAC International" 982.43.
Applied Biosystems,MicroSeq Pharmaceutical Validation Panel. Microbial assay for antibiotics. Tokyo, Japan:Japanese Pharmacopoeia;JP JP14e.part I.34